BMS, Institut Paoli-Calmettes partner again for immuno-oncology research

Bristol-Myers Squibb Co. (NYSE:BMY) said it began an R&D collaboration with the Institut Paoli-Calmettes (Marseille, France) for translational, preclinical and clinical research in immuno-oncology...